inovmedИнновационная медицина КубаниInnovative Medicine of Kuban2541-9897Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1inovmed-34Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESМЕТОДИКА ИССЛЕДОВАНИЯ ПРЕПАРАТА ПОСЛЕ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ РАКА ПРЯМОЙ КИШКИ: КАК МЫ ЭТО ДЕЛАЕМSPECIMEN EXAMINATION FOLLOWING SURGERY FOR RECTAL CANCER: OUR TECHNIQUEПонкинаО. Н.PonkinaO. N.ponkina_olga@mail.ruПоловинкинВ. В.PolovinkinV. V.noemail@neicon.ruНаучно-исследовательский институт – Краевая клиническая больница № 1 им. проф. С.В. Очаповского Министерства здравоохранения Краснодарского краяРоссияState Public Health Budget Institution 'Scientific Research Institute - Ochapovsky Regional Clinic Hospital # 1, Public Health Ministry of Krasnodar RegionRussian Federation201630122016042329Copyright © Понкина О.Н., Половинкин В.В., 20162016Понкина О.Н., Половинкин В.В.Ponkina O.N., Polovinkin V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.innovmedkub.ru/jour/article/view/34

Стандарт хирургического лечения больных раком прямой кишки, тотальная мезоректумэктомия (ТМЭ) требует адекватного патологоанатомического исследования удаленного препарата с целью выявления пациентов с высоким риском развития местного рецидива и отбора пациентов для проведения адъювантной терапии. Врач-патологоанатом должен провести оценку завершенности этой операции (качество хирургического вмешательства), исследовать как дистальный, так и циркулярный края резекции (хирургически мобилизованную поверхность мезоректума), определить хирургический клиренс (расстояние от циркулярного края резекции до опухоли), определить патологическую стадию ((у)рТрN), гистологический тип и степень дифференцировки опухоли. В статье представлена маршрутизация препарата, полученного после хирургического лечения рака прямой кишки, и методика его патогистологического исследования, которая основана на стандартах, предложенных Королевским обществом патологов Великобритании, адаптированных в условиях краевой клинической больницы.

Standard surgical treatment for rectal cancer is a total mesorectumectomy (TME) and it demands performing proper pathohistological examination of the removed specimen to select patients with high risk of local recurrence development and those indicated for adjuvant therapy. Pathologists should value quality of surgical intervention, examine both distal and circular resection margins (surgically mobilized mesorectal surface), define surgical clearance (distance from the circular resection margine to the tumor itself), perform pathological staging ((у)pTpN), determine histological type and stage of tumor differentiation. In this paper we describe a route of the specimen removed after the surgery for rectal cancer and its pathohistological examination technique which is based on the guidances of the British Royal Society of Pathologists specialized to the Regional Clinic Hospital requirements.

мезоректумтотальная мезоректумэктомияшкала оценки качества операциициркулярный край резекциихирургический клиренспредикторы местного рецидиваmesorectumtotal mesorectumectomysurgery quality scalecircular resection marginsurgical clearancelocal recurrence predictorsReferencesHeald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? // Br. J. Surg. Vol. 69 (1982) P. 613 - 616.Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? // Br. J. Surg. Vol. 69 (1982) P. 613 - 616.Quirk P., Williams G.T. Minimum dataset for colorectal cancer histopathology reports. Royal College of Pathologist 2000. (www.rcpath.org).Quirk P., Williams G.T. Minimum dataset for colorectal cancer histopathology reports. Royal College of Pathologist 2000. (www.rcpath.org).Quirk P. Effect of the plane of surgery on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial // Lancet 2009; 373: 821 - 28.Quirk P. Effect of the plane of surgery on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial // Lancet 2009; 373: 821 - 28.Hermanek P., Mansmann U., Staimmer D., et al. The German experience: the surgeon as a prognostic factor in colon and rectal cancer surgery // Surg Oncol Clin North Am. - 2000. - Vol. 9. - P. 33 - 49.Hermanek P., Mansmann U., Staimmer D., et al. The German experience: the surgeon as a prognostic factor in colon and rectal cancer surgery // Surg Oncol Clin North Am. - 2000. - Vol. 9. - P. 33 - 49.Nagtegaal ID., van Krieken JH. The role of pathologists in the quality control of diagnosis and treatment of rectal cancer - an overview // Eur J Cancer. - 2002. - 38(7). - P. 964 - 72.Nagtegaal ID., van Krieken JH. The role of pathologists in the quality control of diagnosis and treatment of rectal cancer - an overview // Eur J Cancer. - 2002. - 38(7). - P. 964 - 72.Maslekar S., Sharma A., MacDonald A. et al. Mesorectal grades predict recurrences after curative resection for rectal cancer // Cancer Colon end Rectum. -2007. - Vol. 50. - № 1. - Р. 168 - 175.Maslekar S., Sharma A., MacDonald A. et al. Mesorectal grades predict recurrences after curative resection for rectal cancer // Cancer Colon end Rectum. -2007. - Vol. 50. - № 1. - Р. 168 - 175.Quirke P., Durdey P., Dixon MF., Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision // Lancet. -1986. - 2(8514). - P. 996 - 9.Quirke P., Durdey P., Dixon MF., Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision // Lancet. -1986. - 2(8514). - P. 996 - 9.Adam I., Mohamdee M., Martin I. Role of circumferential margin involvement in the local recurrence of rectal cancer // Lancet. - 1994. - 344. -P. 707 - 11.Adam I., Mohamdee M., Martin I. Role of circumferential margin involvement in the local recurrence of rectal cancer // Lancet. - 1994. - 344. -P. 707 - 11.Wibe A., Rendedal P.R., Svensson E. et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer // Br. J. Surg. - 2002. - Vol. 89. - P. 327 - 334.Wibe A., Rendedal P.R., Svensson E. et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer // Br. J. Surg. - 2002. - Vol. 89. - P. 327 - 334.Nagtegaal I.D., Marijnen C.A., Kranenbarg E.K., van de Velde CJ. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit // Am J Surg Pathol. - 2002. - 26(3). - P. 350 - 7.Nagtegaal I.D., Marijnen C.A., Kranenbarg E.K., van de Velde CJ. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit // Am J Surg Pathol. - 2002. - 26(3). - P. 350 - 7.Nagtegaal I.D., Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? // J Clin Oncol. - 2008. - 26. - P. 303 - 12.Nagtegaal I.D., Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? // J Clin Oncol. - 2008. - 26. - P. 303 - 12.Собин Л.Х., Госпадарович М.К., Виттекинд К. TNM Классификация злокачественых опухолей (7-е издание) // М.: Логосфера, 2011 - С. 275Собин Л.Х., Госпадарович М.К., Виттекинд К. TNM Классификация злокачественых опухолей (7-е издание) // М.: Логосфера, 2011 - С. 275Gooiker G.E.A., Kolfschoten N.T., Bastiannet E., Van De Velde C., Rosendaal F.R., Tollenaar R.A.E.V., Wouters M.W.J., Behalf O.N. Evaluating the validity of quality indicators for colorectal cancer care // J. Surg Oncol. - 2013. - 108. - P.465 - 571.Gooiker G.E.A., Kolfschoten N.T., Bastiannet E., Van De Velde C., Rosendaal F.R., Tollenaar R.A.E.V., Wouters M.W.J., Behalf O.N. Evaluating the validity of quality indicators for colorectal cancer care // J. Surg Oncol. - 2013. - 108. - P.465 - 571.Tang L.H., Branton P., Burgart L.J., Carter D.K., Fitzgibbons P., Frankel W. L., Halling K.C., Jessup J., Kakar S., Minsky B., Nakhleh R., Washington K., Compton C.C. Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum. College of American Pathologist 2016 (www.CAP.org).Tang L.H., Branton P., Burgart L.J., Carter D.K., Fitzgibbons P., Frankel W. L., Halling K.C., Jessup J., Kakar S., Minsky B., Nakhleh R., Washington K., Compton C.C. Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum. College of American Pathologist 2016 (www.CAP.org).Ryan R., Gibbons D., Hyland J.M.P., et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005; 47(2): 141 - 146. 30.Ryan R., Gibbons D., Hyland J.M.P., et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005; 47(2): 141 - 146. 30.

The authors declare that there are no conflicts of interest present.